Chemical and biologic differences between various H2-receptor antagonists
- PMID: 2906470
- DOI: 10.3109/00365528809099133
Chemical and biologic differences between various H2-receptor antagonists
Abstract
After a brief historical review, the common chemical features of various H2-receptor antagonists are discussed, demonstrating that an imidazole, furan, thiazole, and the piperidinylmethylphenoxy moiety can serve as an aromatic nucleus of histamine H2-receptor antagonists. Furthermore, it is paradigmatically illustrated that the histamine H2-receptor antagonists in use or under clinical investigations inhibit, in a competitive and surmountable manner, parietal cell acid secretion and histamine H2-receptor-linked adenylate cyclase. Furthermore, toxicologic problems of unsurmountable and/or or long-acting histamine H2-receptor antagonists (tiotidine, loxtidine, and SK&F 93479) are discussed.
Similar articles
-
Differences in the interaction of histamine H2 receptor antagonists and tricyclic antidepressants with adenylate cyclase from guinea pig gastric mucosa.Biochem Pharmacol. 1984 Nov 15;33(22):3621-5. doi: 10.1016/0006-2952(84)90147-3. Biochem Pharmacol. 1984. PMID: 6150708
-
Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach.Br J Pharmacol. 1985 Nov;86(3):589-99. doi: 10.1111/j.1476-5381.1985.tb08935.x. Br J Pharmacol. 1985. PMID: 2866003 Free PMC article.
-
Up-regulation of H2 receptor and adenylate cyclase in rabbit parietal cells during prolonged treatment with H2-receptor antagonists.Dig Dis Sci. 1999 Aug;44(8):1703-9. doi: 10.1023/a:1026652119166. Dig Dis Sci. 1999. PMID: 10492156
-
Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.Gastroenterol Clin North Am. 1992 Sep;21(3):527-50. Gastroenterol Clin North Am. 1992. PMID: 1355465 Review.
-
Defining the histamine H2-receptor in brain: the interaction with LSD.NIDA Res Monogr. 1978;(22):38-59. NIDA Res Monogr. 1978. PMID: 30911 Review.
Cited by
-
Roxatidine acetate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic potential in peptic ulcer disease and related disorders.Drugs. 1991 Aug;42(2):240-60. doi: 10.2165/00003495-199142020-00006. Drugs. 1991. PMID: 1717223 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources